In this study, we first found that USP18 impedes ferritinophagy by inhibiting the stability of the NCOA4 protein in HCC cells, thereby reducing intracellular Fe2+ levels and weakening ferroptosis-mediated drug resistance. This evidence concerns the gene USP18 and hepatocellular carcinoma.